Drug Profile
GT 006
Alternative Names: GT006Latest Information Update: 28 Jan 2020
Price :
$50
*
At a glance
- Originator Lund University
- Developer Gabather
- Class Small molecules
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anxiety disorders; Psychotic disorders
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for preclinical development in Anxiety-disorders in Sweden
- 28 Jan 2020 No recent reports of development identified for preclinical development in Psychotic-disorders in Sweden